Background: To enhance indicated prevention in patients with a clinical high risk (CHR) 
Introduction
The early detection and treatment of psychoses already in their prodromal stage have become widely accepted goals in psychiatry during the last two decades (Fusar-Poli et al., 2013b) . Consequently, a number of operational criteria aiming at identifying patients with a clinical high risk (CHR) for psychosis have been established internationally.
However, meta-analyses suggest that -among help-seeking individuals -about one third of those meeting internationally established CHR criteria will develop psychosis within five years (Fusar-Poli et al., 2012 , Schultze-Lutter et al., 2015 with about 73% of these developing schizophrenic psychoses (Fusar-Poli et al., 2013a) and about one third is having a clinical remission within two years (Simon et al., 2013) . Hence, risk stratification of CHR patients offers great potential for enhancing clinical decision making and improving the cost-benefit ratio of preventive interventions . Accordingly, recent research efforts have been increasingly directed toward estimating the risk of developing psychosis on an individual level. The trend towards indicated prevention and personalized medicine in early stages of psychosis is exemplified by the fact that several large multicenter studies (i.e. PRONIA, PSYSCAN and NAPLS III) are currently underway aiming at developing prognostic tools in CHR patients. Furthermore, an ever-increasing number of studies are seeking to improve the prediction of psychosis in CHR patients by incorporating single risk factors and indicators into multivariable prediction models (e.g. Cannon et al., 2008 , Riecher-Rössler et al., 2009 , Ruhrmann et al., 2010 . By using the term multivariable models we refer to models with multiple predictor variables (i.e. independent variables) and one outcome variable (i.e. dependent variable) as opposed to multivariate models, which have multiple outcome variables (Hidalgo and Goodman, 2013) .
However, despite considerable research efforts, no psychosis risk prediction model has yet been adopted in clinical practice. The most likely explanation for this is that none of the published models has yet been convincingly demonstrated to have sufficient validity and clinical utility. While a lack of progress in this area could be partly attributed to the fact that psychoses are complex disorders with large phenomenological, pathophysiological, and etiological heterogeneity (Keshavan et al., 2011) and that there are heterogeneous subgroups within CHR samples (Fusar-Poli et al., 2016) , another important obstacle to consider is the widespread use of poor (i.e., biased and inefficient) modelling strategies, which can severely compromise the reliability and validity of the developed models. Examples of poor modelling strategies are relying on small event per variable (EPV) ratios (i.e. small number of patients with transition to psychosis relative to the number of considered predictor variables), using biased methods to select predictor variables for inclusion into the multivariable prediction model among a set of candidate predictor variables, not properly assessing the predictive accuracy of the model, using inappropriate model types, and not efficiently dealing with missing data (D'Amico et al., 2016 , Wynants et al., 2016 . Systematic reviews on the methodology of studies developing clinical prediction models for type 2 diabetes (Collins et al., 2011) , cancer (Mallett et al., 2010) , traumatic brain injury outcome (Mushkudiani et al., 2008) , kidney disease (Collins et al., 2013) , or medicine in general (Bouwmeester et al., 2012) all found that the use of such methods is widespread. Hence, it is reasonable to assume that poor methods are also a widespread problem in prediction of psychosis research.
Unfortunately, a systematic review on the methodology and reporting of studies developing or validating models predicting psychosis in CHR patients using rigorous quality criteria has not yet been conducted. Although one systematic review (Strobl et al., 2012) has focused on methods and performance of models predicting the onset of psychosis, several critical aspects, such EPV ratios, selection of predictor variables, assessment of predictive performance, and dealing with missing data, were not addressed. This might be because up until recently, no guidance existed to help form a well-defined review question and determine which details to extract and critically appraise from prediction modelling studies (Moons et al., 2014) . Fortunately, such guidance has now become available with the publication of the Checklist for critical Appraisal and data extraction for systematic Reviews of Prediction Modelling Studies (CHARMS; Moons et al., 2014) which was developed by a panel of experts of the Cochrane Prognosis Methods Group.
The present systematic review therefore aims to critically appraise the methodology and reporting of studies developing or validating models predicting psychosis in CHR patients. We reviewed prediction modelling studies regardless of the domains predictor variables were selected from. In accordance with the recently published CHARMS and other guidelines on clinical prediction modelling (e.g., Altman et al., 2012 , Collins et al., 2015 , all important methodological issues are addressed, including effective sample size, type of model used, selection and transformation of variables, assessment of predictive performance, internal and external validation, and treatment of missing data.
The ultimate goal of this paper is to enhance the methodology and reporting of future studies not only by identifying frequent sources of bias but also by giving recommendations for improvement. To facilitate understanding, brief explanations of key statistical concepts in prognostic modelling are provided in Table 1 (see also Fusar-Poli and Schultze-Lutter, 2016).
Methods

Search strategy
A literature search was carried out (up to March 14, 2016) in the databases of Medline, Embase, PsycINFO, and Web of Science using the following search terms: (predict* OR "vulnerability marker" OR "risk factors for transition") AND psychosis AND ("clinically at high risk" OR "clinically at risk" OR "clinical high risk" OR "ultra high risk" OR prodrom* OR "at risk mental state" OR "risk of psychosis"). The search was restricted to English language papers published from 1998 onwards because this marks the time when the first prospective studies with patients meeting validated clinical high risk criteria were published (Yung et al., 1998) . The publication type was restricted to articles only, thus excluding meeting abstracts, editorials, letters, reviews and comments. In addition, the reference lists of the included studies were screened to identify further potentially relevant studies.
Study selection
Studies were included if they met the following criteria: (1) involved subjects with a CHR for psychosis that were prospectively followed up, (2) developed or validated a prognostic model that predicted later transition to psychosis from variables obtained at baseline, (3) included at least two predictor variables in the prognostic model. CHR for psychosis was required to be diagnosed by internationally established criteria.
That is, subjects had to fulfill either ultra-high risk (UHR), basic symptom (BS), or Unspecific Prodromal Symptom (UPS) criteria (for review, see Fusar-Poli et al., 2013b) .
Studies with overlapping samples were not excluded since the focus or our review was on methodology and reporting and not on the predictive performance of different models or the predicitive potential of different predictor variables.
Studies were selected in a two-step procedure: First, all references retrieved from the databases were screened based on their titles and abstracts. Next, articles that were found to be potentially eligible were further evaluated based on their full texts. The study selection was performed by the first author and randomly checked by the second author.
Discrepancies in the final classification were discussed until consensus was reached.
Data extraction
We developed a comprehensive item list based on current methodological recommendations for developing and reporting clinical prediction models. To this end, we studied the item lists of previous systematic reviews evaluating prediction research in other medical fields (Bouwmeester et al., 2012 , Collins et al., 2011 , Collins et al., 2013 , Mallett et al., 2010 , Mushkudiani et al., 2008 , van Oort et al., 2012 , existing reporting statements and checklists (i.e., the CHARMS, Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD; Collins et al., 2015) , Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK; Altman et al., 2012) , as well as current text books (Harrell, 2001 , Steyerberg, 2009 ) and articles , Moons et al., 2009a , Moons et al., 2009b , Steyerberg et al., 2010 on clinical prediction modeling. The first author extracted all data, which was randomly checked by the second author. Discrepancies were resolved by mutual discussions.
Data analysis
In line with a recent systematic review on clinical prediction research (Bouwmeester et al., 2012) we distinguished between predictor finding studies, prediction model development studies, and external validation studies. Predictor finding studies primarily aim to explore which predictors independently contribute to the prediction of the outcome, i.e. are associated with the outcome (Bouwmeester et al., 2012 , Moons et al., 2009b . By contrast, model development studies aim to develop multivariable prediction models for clinical practice (i.e. for informed decision making) that predict the outcome as accurately as possible. While both types of studies make use of multivariable prediction models, the focus of the first is more on causal explanation and hypothesis testing whereas the latter is more concerned with accurate prediction. Although there are clear similarities in the design and analysis of etiological and prognostic studies, there are several aspects in which they differ. For example, calibration and discrimination are highly relevant to prognostic research but meaningless in etiological research (Moons et al., 2009b) . Furthermore, establishing unbiased estimates of each individual predictor with the outcome is important in etiological research but not in prognostic research (for more details on the difference between prognostic and etiological research, see Moons et al., 2009b , Seel et al., 2012 .
Studies were categorized as predictor model development studies if it was clearly stated in the manuscript that the aim was developing a model for clinical practice and not merely testing the predictive potential of certain predictor variables or domains. Studies were categorized as external validation studies if their aim was to assess the performance of a previously reported prediction model using new participant data that were not used in the development process. All other studies fulfilling inclusion criteria were termed predictor finding studies.
Since it would have been unfair to evaluate the different study types by exactly the same criteria, we grouped results by study type whenever necessary. Each extracted item was summarized in terms of absolute and relative frequencies and the results are reported according to the PRISMA guidelines (Moher et al., 2009) .
Results
Literature search results
The literature search identified 91 articles eligible for full review (see Supplementary Table S1 .
Study aims
Only 7 studies (Cannon et al., 2008 , Chan et al., 2015 , Michel et al., 2014 , Nieman et al., 2014 , Perkins et al., 2015a , Perkins et al., 2015b , Ruhrmann et al., 2010 ) (8%) aimed at developing a clinical prediction model for application in clinical practice and thus were categorized as model development studies. All other studies (92%) where considered predictor finding studies.
We did not identify any true external validation studies. Although Mason et al. (2004) aimed at replicating the results of Yung et al. (2004) and Thompson et al. (2011) aimed at replicating the results of Cannon et al. (2008) , both studies did not evaluate an exact published model (i.e., applied a regression formula to new data) but re-estimated regression coefficients of previously identified predictors. As frequently pointed out in the literature (e.g., Moons et al., 2014, Royston and Altman, 2013) , such studies are not model validation studies, but should be considered model re-development studies.
Study designs
All studies where cohort studies, except one which used a nested cohort design. Sixty six studies (73%) were single-center and 25 (28%) were multicenter studies. Data were collected at 27 different centers. Many studies had overlapping samples. For instance, more than one fourth (25.3%) of the published studies were based on data collected at the Personal Assessment and Crisis Evaluation (PACE) clinic in Melbourne, although not always from the same time periods. The used criteria for identifying CHR patients and assessing transition to psychosis are displayed in Supplementary Table 2 . The length and frequency of follow-up differed markedly between studies. Whereas some studies assessed transition to psychosis on a monthly basis in the first year (e.g., Riecher-Rössler et al., 2009) , others conducted follow-up assessments only on a yearly or less frequent basis, which poses the risk of missing at least some transitions and might lead to a less accurate estimation of the time to transition. The average follow-up duration (from the 84 studies it could be determined) was 33.1 months (median: 27.9 months, range: 12-90 months). 17% of these studies had a follow-up duration of only one year, 33% of less than 2 years, and 60% of less than 3 years.
Number of patients and transitions
The average number of included CHR patients per study was 128 (SD: 134) and the average number of transitions was 29.8 (SD: 25.2). Although model development studies tended to have a higher number of included patients and transitions than predictor finding studies (252 vs. 118 and 56.1 vs. 27.6, respectively), these differences did not reach statistical significance. The average proportion of patients with later transition to psychosis was 27% (median: 26%, range: 5-53%). Since for a binary or a time-to-event outcome the effective sample size is the smaller of the two outcome frequencies (Moons et al., 2015) , the effective sample size in the included studies almost always corresponded to the number of cases with later transition to psychosis and thus on average was only about one fourth of the number of included CHR patients.
Number and type of considered predictor variables
The number of considered predictor variables could be determined in 85 studies (93%) and was 23.7 on average (median: 12, SD: 36.9, range: 2-225). Model development studies considered significantly more predictor variables than predictor finding studies (97 vs. 17.1 predictors, p = 0.040). The most frequently covered domains were positive symptoms, followed by negative symptoms, socio-demographic characteristics, and general, social-and occupational functioning (see Figure 2) .
Event per variable ratio
The average number of events per considered predictor variable (EPV) was 3 (median:
1.8, SD: 3, range: 0.1-14.3). Although model development studies tended to have smaller average EPV than predictor finding studies (1.8 vs. 3.1), this difference did not reach statistical significance. Only 3 studies (Stowkowy et al., 2016 , Velthorst et al., 2013a , Walder et al., 2013 ) (3.5%), all of which were predictor finding studies, had an EPV of at least 10.
Missing data
Missing data at baseline was only explicitly mentioned in 28 studies (31%). The number of subjects with missing data was reported in 24 studies (26%), the number of missing values for each predictor in 11 studies (12%), and the number of subjects lost to followup in 35 studies (38%). Nine studies (10%) reported to have omitted at least one predictor with missing values. The vast majority of studies handled missing data by performing complete case analyses, although this was only made explicit in 26 studies (29%) and must be assumed for those studies that did not mention missing data. (Moons et al., 2015) Multiple imputation was only used in four studies (4%) (Nieman et al., 2014 , Nieman et al., 2013 , Rüsch et al., 2015 , Seidman et al., 2010 while single imputation was applied in two studies (2%) (Cornblatt et al., 2015 , Demjaha et al., 2012 .
Model types
The most frequently used model types were Cox proportional hazard and logistic regression models, which were used in 51 (56%) and 23 (25%) studies, respectively.
Five studies (5.5%) had fitted both of these models. A small number of studies applied more modern statistical learning methods, such as support vector machines (Koutsouleris et al., 2012a , Koutsouleris et al., 2012b , Koutsouleris et al., 2009 , Koutsouleris et al. (2015) (4%), least absolute shrinkage and selection operator (LASSO) (Chan et al., 2015 , Ramyead et al., 2015 (2%), greedy algorithm (Perkins et al., 2015a , Perkins et al., 2015b ) (2%), partial least squares discriminant analysis (Huang et al., 2007 ) (1%) and convex hull classification (Bedi et al., 2015) (1%). Linear discriminant analysis was used in one study (Mittal et al., 2010 ) (1%). One study (Healey et al., 2013) (1%) appeared to have used an ordinary least square regression model with a binary outcome, which clearly violates modelling assumptions.
Selection of predictor variables and dimensionality reduction
Pre-selection of candidate predictors for inclusion in the multivariable analyses based on univariable predictor-outcome associations was performed in 32 studies (35%). Six studies reduced the number of predictors before inclusion to the final models by applying dimensionality reduction methods, such as principal component analysis (Huang et al., 2007 , Koutsouleris et al., 2012a , Koutsouleris et al., 2009 , Koutsouleris et al., 2015 , Raballo et al., 2011 , exploratory factor analysis (Demjaha et al., 2012) and latent class factor analysis (Velthorst et al., 2013a) .
For selecting predictors within multivariable models, 34 studies (37%) used stepwise methods. Most of these used backward elimination methods, but six studies also used forward and backward stepwise, five used forward stepwise and two did not describe the specific stepwise method. Nine studies (10%) applied stepwise variable selections in multiple steps, that is, first to each of several domains, and then to the variables retained in each domain. The most frequently used significance threshold for stepwise variable selection was p = 0.05. Automated variable selection within multivariable models using non-stepwise-methods was conducted in only four studies. Two of these (Chan et al., 2015 , Ramyead et al., 2015 used the LASSO and two (Perkins et al., 2015a , Perkins et al., 2015b a greedy algorithm.
Transformation of predictor variables
Three of the model development studies (Cannon et al., 2008 , Perkins et al., 2015b , Ruhrmann et al., 2010 ) (43%) and 10 of the predictor finding studies (Amminger et al., 2006 , Cornblatt et al., 2015 , DeVylder et al., 2014 , Mason et al., 2004 , Nelson et al., 2013 , O'Donoghue et al., 2015 , Velthorst et al., 2013b , Yung et al., 2003 , Yung et al., 2004 ) (12%) fitted prediction models based on categorized or dichotomized continuous variables. Six of these (Cannon et al., 2008 , Mason et al., 2004 , Nelson et al., 2013 , Yung et al., 2003 , Yung et al., 2004 chose categorization cut-points based on the lowest p-value, one (DeVylder et al., 2014) based on the maximal area under the Receiver Operating Characteristic (ROC) curve (AUC), one (O'Donoghue et al., 2015) based on quartiles, and 5 studies (Amminger et al., 2006 , Cannon et al., 2008 , Perkins et al., 2015b , Ruhrmann et al., 2010 , Velthorst et al., 2013b did not provide explanations for the chosen cut-points. In at least four studies (Mason et al., 2004 , Nelson et al., 2013 , Yung et al., 2003 , Yung et al., 2004 ) the reason of dichotomizing continuous predictor variables was to provide a simple scoring rule. If model performance was assessed, this was mainly done using classification measures, such as sensitivity and specificity, and less frequently using overall performance and discrimination measures. Calibration was not assessed in any of the model development studies and only in five (5%) of the predictor finding studies. Four of these (Cornblatt et al., 2015 , Piskulic et al., 2012 , Rüsch et al., 2015 , Xu et al., 2016 used the HosmerLemeshow statistic and one (Perkins et al., 2015b ) a calibration plot. From the 31 studies reporting at least one classification measure, 19 did not report the probability threshold for classification and whether it was chosen from the data or set a priori, three used model types that did not predict a probability, and eight chose the probability threshold from the data. From the 35 studies (38%) reporting at least one performance measure, 21 (60%) only reported the so called apparent performance.
Model performance
Model evaluation
Internal cross validation was carried out in only four of the model development studies (57%) (Michel et al., 2014 , Nieman et al., 2014 , Perkins et al., 2015a , Perkins et al., 2015b ) and 10 of the predictor finding studies (12%) (Bedi et al., 2015 , Cornblatt et al., 2015 , Koutsouleris et al., 2012a , Koutsouleris et al., 2012b , Koutsouleris et al., 2009 , Koutsouleris et al., 2015 , Mittal et al., 2010 , Ramyead et al., 2015 , Riecher-Rössler et al., 2009 , Schultze-Lutter et al., 2007 . Six of these (Koutsouleris et al., 2012a , Koutsouleris et al., 2012b , Koutsouleris et al., 2009 , Koutsouleris et al., 2015 , Perkins et al., 2015a , Ramyead et al., 2015 used k-fold cross validation, three (Cornblatt et al., 2015 , Michel et al., 2014 , Nieman et al., 2014 used bootstrapping, three (Bedi et al., 2015 , Mittal et al., 2010 , Riecher-Rössler et al., 2009 ) used leave-one-out-cross-validation and two (Perkins et al., 2015b , Schultze-Lutter et al., 2007 used a split-sampling approach.
However, five of these studies (Cornblatt et al., 2015 , Michel et al., 2014 , Mittal et al., 2010 , Nieman et al., 2014 , Riecher-Rössler et al., 2009 ) only cross-validated the final model and therefore did not take into account the uncertainty introduced by the variable selection and transformation. Only four studies (Koutsouleris et al., 2012a , Koutsouleris et al., 2012b , Koutsouleris et al., 2015 , Ramyead et al., 2015 used nested repeated cross-validation, which is considered the best approach for training and testing a prediction model in one sample (Krstajic et al., 2014) .
Model presentation
Only four studies (Schultze-Lutter et al., 2012 , Schultze-Lutter et al., 2007 , Xu et al., 2016 , Ziermans et al., 2014 ) (4%) provided the full model formula, seven (8%) used model types that cannot be easily described with a model formula (e.g. support vector machine), 20 (22%) only provided p-values but not regression coefficients of predictors, and 60 studies (66%) only provided regression coefficients of the predictor variables but not the intercept or baseline survival function, which are required in logistic and Cox regression, respectively, to properly assess calibration (Moons et al., 2015, Royston and Altman, 2013) . Three studies (Bang et al., 2015 , Lencz et al., 2006 , Riecher-Rössler et al., 2009 ) also only provided regression coefficients for standardized or otherwise transformed variables without giving enough details to exactly replicate the variable transformation in a new data set.
Discussion
Our systematic review identified 91 studies using a multivariable clinical prediction model for predicting the transition to psychosis in CHR patients. The vast majority of these studies (n = 84) were classified as predictor finding studies because they primarily aimed at hypothesis testing or evaluating the predictive potential of certain predictors or assessment domains. Only 7 studies stated explicitly that they aimed at developing a prediction model for clinical practice and therefore were classified as model development studies. Thus, in prediction of psychosis research, studies seem to focus much more often on etiology/explanation than maximizing prognostic accuracy (for a more detailed explanation of the difference between prognostic and etiological research, see Moons et al., 2009b , Seel et al., 2012 . However, it should be noted that this distinction was not always clear-cut as many authors did not clearly describe the aim of the study or possibly tried to achieve both accurate prognosis and a better understanding of causal relationships.
We found that poor conduct and reporting were widespread in both predictor finding and model developed studies and that almost all aspects of the modelling process were affected. The results of this review are therefore consistent with reviews of prediction modelling studies in other medical fields (Bouwmeester et al., 2012 , Collins et al., 2011 , Collins et al., 2013 , Mallett et al., 2010 , Mushkudiani et al., 2008 .
One of the biggest concerns is that most studies relied on small effective sample sizes and number of events (i.e. patients with later transitions to psychosis) relative to the number of considered predictor variables (EPV). Small EPV ratios increase the risk of overfitting and overestimating the performance of the model, if it is developed and assessed in the same sample (Moons et al., 2015) . Furthermore, it can lead to biased regression coefficients and unstable variable selection (Mushkudiani et al., 2008) .
Current guidelines and textbooks therefore recommend EPV ratios of at least 10 (Collins et al., 2015 , Moons et al., 2014 , Steyerberg, 2009 . Unfortunately, in this review, an EPV of at least 10 was only achieved in three studies (Stowkowy et al., 2016 , Velthorst et al., 2013a , Walder et al., 2013 and the median EPV was only 1.8. While low EPV ratios have also frequently been criticized in other fields of clinical prediction research (Bouwmeester et al., 2012 , Collins et al., 2011 , the problem seems to be particularly severe in prediction of psychosis as reviews on studies developing models predicting cancer (Mallett et al., 2010) , kidney disease (Collins et al., 2013) , type 2 diabetes (Collins et al., 2011) , and cardiovascular disease (Wessler et al., 2015) have reported median EPV ratios of 10, 29, 19, and 11-34, respectively. The much lower sample sizes in prediction of psychosis research can be at least partially explained by the fact that CHR patients are difficult to recruit and follow-up durations of at least two years are needed to detect most later transitions to psychosis (Kempton et al., 2015) .
However, although missing data is expected to be frequent in medical research in general (Sterne et al., 2009) and in early psychosis research in particular, only about one third of the included studies mentioned any missing data. Furthermore, reporting on the type and frequency of missing data was often poor. Moreover, only 4 studies (Nieman et al., 2014 , Nieman et al., 2013 , Rüsch et al., 2015 , Seidman et al., 2010 (4%) performed multiple imputation, which is generally acknowledged as the preferred method for handling incomplete data (Moons et al., 2014 , Sterne et al., 2009 . Hence, it is likely that most studies had excluded subjects or variables with incomplete data, which not only leads to a waste of data and reduced power, but can also negatively affect the representativeness of the sample and consequently the generalizability of the resulting prediction model (Gorelick, 2006 , Moons et al., 2015 . Unfortunately, poor handling and reporting of missing data is widespread in any medical field (Bouwmeester et al., 2012) .
However, in prediction of psychosis the consequences might be particularly severe as samples are already quite small and a further loss of data can be less afforded.
Approximately 60% of both predictor finding and model development studies used Cox regression and thus treated the outcome as a time-to-event variable, whereas the remaining studies used models with a binary outcome (i.e. transition vs. non-transition).
For prospective studies with longer-term diagnostic outcomes and regular follow-up assessments, as is the case in prediction of psychosis studies, time-to-event outcome models are more appropriate because they use more information, have more statistical power, and can deal with censoring (i.e. cases with incomplete follow-up) (Moons et al., 2015 , van der Net et al., 2008 . Since loss to follow-up is frequent in prediction of psychosis research and follow-up durations often too short to capture all transitions (Schultze-Lutter et al., 2015) , the 40% of studies that have applied a binary outcome model are mainly faced with two shortcomings. First, they had to exclude nontransitioned cases with short follow-up durations, which again further aggravated the problem of already existing small sample sizes and might have hampered the representativeness of the sample. Second, patients with late transition to psychosis might have been misclassified as non-transitioned cases.
Several studies (Koutsouleris et al., 2012a , Koutsouleris et al., 2012b , Koutsouleris et al., 2009 , Koutsouleris et al., 2015 used so called machine learning or pattern recognition methods, such as support vector machines. In line with , we herein use the term "machine learning method" to refer to the more modern and flexible statistical learning methods originally developed in the field of computer science, such as random forest or neural networks, which can automatically capture highly complex nonlinear relationships between predictor and response variables, and separate them from regression based methods traditionally used in clinical prediction modelling, such as logistic and Cox regression or penalized versions thereof (i.e. models in which regression coefficients are shrunken towards zero, such as LASSO). Since first results with machine learning methods have been encouraging, a more widespread use of these methods in the field of early detection of psychosis is now considered by many authors a promising strategy to improve the prediction of psychosis (Koutsouleris and Kambeitz, 2016, Pettersson-Yeo et al., 2013) . However, many methodologists in the field of clinical prediction modelling (Moons et al., 2015 do not share this enthusiasm for the following reasons: First, due to their higher flexibility, machine learning methods are more prone to overfitting than regression based approaches, particularly in small data sets . Hence, when sample sizes are small, as is frequently the case in prediction of psychosis research, their performance advantage resulting from the increased ability to capture the true underlying relationship between predictors and response might not be high enough to compensate for the increased tendency to overfit . Accordingly, van der Ploeg et al.
have shown that logistic regression outperformed support vector machines, random forests and neural networks in external validation, when predicting 6-month mortality in traumatic brain injury patients from socio-demographic, computed tomography, and laboratory data (van der Ploeg et al., 2016) . Similarly, logistic regression outperformed random forest and support vector machines, when predicting treatment resistance in major depressive disorder (Perlis, 2013) . Of course, this does not mean that machine learning methods would also perform worse in every prediction of psychosis scenario (for example, they might still be superior when predicting psychosis from neuroimaging data).
However, based on the above findings, it seems rather unlikely that they would be vastly superior in most scenarios. Second, machine learning methods are less interpretable and more difficult to communicate to clinicians . For example, regression models can transparently be presented, with insight in relative effects of predictors by odds or hazard ratios, while many machine learning models are essentially black boxes with highly complex prediction equations. Third, while traditional methods can be easily adjusted to local settings (e.g. by changing the model intercept), this is more difficult for machine learning methods . However, the ability to adjust the model, also called re-calibration (Steyerberg, 2009) , is important in prediction of psychosis, as rates of transition to psychosis have been shown to vary considerably across time and location (Fusar-Poli et al., 2012) .
With regard to variable selection strategies, we found that univariable screening of candidate predictors and/or stepwise variable selection were frequently conducted in both predictor finding and model development studies. However, these methods have long been criticized on multiple grounds (Harrell, 2001 , Nunez et al., 2011 , Steyerberg, 2009 ). Specifically, when the EPV ratio is low, the variable selection is unstable, the size and significance of the estimated regression coefficients are systematically overestimated, and the performance of the selected model is overoptimistic (Derksen and Keselman, 1992 , Steyerberg et al., 1999 , Steyerberg and Vergouwe, 2014 , Sun et al., 1996 . Since the bias introduced by these methods is more severe when EPV ratios are low, their use in prediction of psychosis research is particularly problematic.
Unfortunately, we also found that most studies relied on high significance thresholds, such as p < 0.05, for variable selection, which leads to more bias and worse cross-validated predictive performance than higher thresholds, particularly in small data sets (Steyerberg et al., 1999 , Steyerberg et al., 2001 . Furthermore, we found that several studies performed forward stepwise instead of the more recommended backward stepwise selection (Nunez et al., 2011 , Steyerberg, 2009 . Given that sample sizes in the field of early psychosis research are small, a more sensible approach for variable selection would be to rely more on external knowledge. For example, candidate predictors could be pre-selected by performing meta-analyses or based on theory. If external knowledge is not available, a more stable set of predictor variables and reduced overfitting can be achieved by applying shrinkage methods (Nunez et al., 2011 , Steyerberg et al., 2001 , such as the LASSO (Tibshirani, 1997) , which have only been used in two (Chan et al., 2015 , Ramyead et al., 2015 of the included studies.
We also found several studies that categorized or even dichotomized continuous predictor variables, which has been strongly discouraged by methodologists because it leads to a considerable loss of information, reduced statistical power, residual confounding, and decreased predictive accuracy (Altman et al., 2012 , Collins et al., 2016 , Royston et al., 2006 . Furthermore, many of these studies chose cut-points by taking the value that produced the lowest p or highest AUC value, which can lead to a serious inflation of the type I error and to an overestimation of the prognostic effect (Altman et al., 2012 , Hollander et al., 2004 .
Another area that needs considerable improvement concerns model performance assessment and evaluation, although this is clearly more important for model development and less so for predictor finding studies. We found that none of the proposed models has been externally validated and internal cross-validation was carried out in only 57% of model development studies and 12% of predictor finding studies.
Furthermore, half of these used poor internal cross-validation strategies, such as splitsampling, which wastes half of the data and leads to highly uncertain estimates of model performance (Austin and Steyerberg, 2014, Moons et al., 2015) , or cross-validating only the final model after having conducted data-driven variable selection in the whole sample, which leads to highly overoptimistic performance estimates (Krstajic et al., 2014 ).
Since internal cross-validation was conducted infrequently, most studies only reported the so called "apparent" performance, which tends to be strongly overoptimistic because it is calculated in the same data as used for model building (Moons et al., 2015) .
Furthermore, most studies did not report the whole spectrum of recommended performance measures. For example, calibration, which is a key aspect of the model performance (Moons et al., 2015) , was rarely assessed and mostly using the HosmerLemeshow statistic instead of the more recommended calibration-in-the-large and calibration slope (Collins et al., 2015 , Steyerberg et al., 2010 . Moreover, many studies reporting classification measures (i.e. sensitivity and specificity) had searched for optimal probability thresholds for classification in the same sample as they used for testing, which again likely contributed to overoptimism (Leeflang et al., 2008 ).
We also found major deficiencies in the way models were presented. Most importantly, most studies did not provide enough details to exactly apply the model in a new data set, which might at least partially explain why none of these models has yet been externally validated. Furthermore, several studies only provided enough details to apply a simplified scoring rule but not the original model. However, as explained above, the perceived advantage of simplification/categorization comes at high costs. A much better way of facilitating the clinical application would be the creation of an online risk calculator (Steyerberg and Vergouwe, 2014) . This would also allow the clinical use and external validation of more complex models (e.g. machine learning algorithms) that cannot be described with a simple model formula .
Limitations
Our literature search was restricted to English language journal articles only. Thus, it is possible that some relevant literature has been missed. A further limitation is that choosing an appropriate modelling strategy is complex and depends on many different factors, including research question, study design, sample size and number of variables.
Although we grouped studies by their aim and relied on guidelines (i.e. the CHARMS) for critically appraising the methodology and reporting of the included studies as much as possible, some studies might have been treated unfairly due to not taking all specific factors into account.
Conclusion
Taken together, we found that most studies developing a model for predicting the transition to psychosis in CHR patients were poorly conducted and reported. Biased and inefficient methods, such as complete case analysis, modelling a time-to-event outcome as a binary outcome, data-driven univariable and stepwise selection of candidate variables, categorization of continuous predictors, and assessing only the apparent predictive performance, were widespread and often applied together and in data sets with small EPV ratios, which likely potentiated their harmful consequences.
Consequently, most published predictive performance estimates in this field are likely considerably overoptimistic. Unfortunately, this was rarely acknowledged, since proper internal validation was infrequent and external validation not attempted. An essential requirement for future studies is therefore to improve model validation. While we acknowledge that -due to differences in measurement methods across centersexternal validation is often difficult, internal validation can and should always be performed (Moons et al., 2012) . To further enhance progress, future studies should more strictly adhere to current checklists and guidelines on clinical prediction models, such as the recently published TRIPOD statement (Collins et al., 2015 , Moons et al., 2015 .
Since EPV ratios in prediction of psychosis research are small compared to other fields of prediction research, researchers in this field should take extra care to not waste valuable information and to avoid overfitting, for example, by more strongly relying on external information and applying models that are not too adaptive. In Table 3 , we have summarized our recommendations for improved methodology and reporting in prediction of psychosis studies. , P., Bonoldi, I., Yung, A. R., Borgwardt, S., Kempton, M. J., Valmaggia, L., Barale, F., 
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